References

Agoulnik IU, Krause WC, Bingman WE, III, Rahman HT, Amrikachi M, Ayala GE, Weigel NL (2003) Repressors of androgen and progesterone receptor action. J Biol Chem 278:3113631148

Anderson RA, Wallace AM, Sattar N, Kumar N, Sundaram K (2003) Evidence for tissue selectivity of the sysnthestic androgen 7alpha-methyl-19-nortestosterone in hypogonadal men. J Clin Endocrinol Metab 88:2784-2793 Azcoitia I, Sierra A, Veiga S, Honda S, Harada N, Garcia-Segura LM (2001) Brain aromatase is neuroprotective. J Neurobiol 47:318-329 Berrevoets CA, Umar A, Brinkmann AO (2002) Antiandrogens: selective androgen receptor modulators. Mol Cell Endocrinol 189: 97-103 Berry M, Metzger D, Chambon P (1990) Role ofthe two activating domains ofthe oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen. EMBO JY 9:2811-2818 Brzozowski AM, Pike AC, Dauter Z, Hubbard RE, Bonn T, Engstrom O, Ohman L, Greene GL, Gustafsson JA, CarlquistM (1997) Molecular basis ofagonism and antagonism in the oestrogen receptor. Nature 389:753-758 Carani C, Rochira V, Faustini-Fustini M, Balestrieri A, Granata AR (1999) Role of oestrogen in male sexual behaviour: insights from the natural model of aromatase deficiency. Clin Endocrinol 51:517-524

Castoria G, Lombardi M, Barone MV, Bilancio A, Di Domenico M, Bottero D, Vitale F, Migli-accio A, Auricchio F (2003) Androgen-stimulated DNA synthesis and cytoskeletal changes in fibroblasts by a nontranscriptional receptor action. J Cell Biol 161:547-556 Cato AC, Nestl A, Mink S (2002) Rapid actions of steroid receptors in cellular signaling pathways. SciSTKE 138:RE9

Chengalvala M, Oh T, Roy AK (2003) Selective androgen receptor modulators. Expert Opin Ther Patents 13:59-66

Cosman F and Lindsay R (1999) Selective estrogen receptor modulators: clinical spectrum. Endocr Rev 20:418-434

Cummings DE, Kumar N, Bardin CW, Sundaram K, Bremner WJ (1998) Prostate-sparing effects in primates of the potent androgen 7alpha-methyl-19-nortestosterone: a potential alternative testosterone for androgen replacement and male contraception. J Clin Endocrinol Metab 83:4212-4219

Fields S and Song O (1989) A novel genetic system to detect protein-protein interactions. Nature 340:245-246

Ghali SA, Gottlieb B, Lumbroso R, Beitel LK, Elhaji Y, Wu J, Pinsky L, Trifiro MA (2003) The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity. J Clin Endocrinol Metab 88:2185-2193 Gooren LJ (1985) Human male sexual functions do not require aromatization of testosterone: a study using tamoxifen, testolactone, and dihydrotestosterone. Arch Sex Behav 14:539-548 Hamann LG, Mani NS, Davis RL, Wang XN, Marschke KB, Jones TK (1999) Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6-(trifluoromethyl)-8-pyridono[5,6-7 ]- quinoline (LG121071). J Med Chem 42:210-212 Han G, Foster BA, Mistry S, Buchanan G, Harris JM, Tilley WD, Greenberg NM (2001) Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer. J Biol Chem 276:11204-11213

Harada N, Utsumi T, Takagi Y (1993) Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc. Natl Acad Sci USA 90:1131211316

He B, Kemppainen JA, Wilson EM (2000) FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J Biol Chem 275:22986-22994

Heinlein CA and Chang C (2002) Androgen receptor (AR) coregulators: an overview. Endoc Rev 23:175-200

Hermanson O, Glass CK, Rosenfeld MG (2002) Nuclear receptor coregulators: multiple modes of modification. Trends Endocrinol Metab 13:55-60

Hershberger L and Shipley EMR (1953) Myotropic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method. Proc Soc Exp Biol Med 83:175180

Hofbauer LC, Ten RM, Khosla S (1999) The anti-androgen hydroxyflutamide and androgens inhibit interleukin-6 production by an androgen-responsive human osteoblastic cell line. J Bone Miner Res 14:1330-1337

Hsiao PW and Chang C (1999) Isolation and characterization of ARA160 as the first androgen receptor N-terminal-associated coactivator in human prostate cells. J Biol Chem 274:2237322379

Kang HY, Yeh S, Fujimoto N, Chang C (1999) Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor. J Biol Chem 274:8570-8576

Katzenellenbogen BS and Katzenellenbogen JA (2002) Biomedicine. Defining the "S" in SERMs. Science 295:2380-2381

Kemppainen JA, Langley E, Wong CI, Bobseine K, Kelce WR, Wilson EM (1999) Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medrox-yprogesterone acetate and dihydrotestosterone. Mol Endocrinol 13:440-454

Kousteni S, Bellido T, Plotkin LI, O'Brien CA, Bodenner DL, Han L, Han K, DiGregorio GB, Katzenellenbogen JA, Katzenellenbogen BS, Roberson PK, Weinstein RS, Jilka RL, Manola-gas SC (2001) Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity. Cell 104:719-730

Kousteni S, Han L, Chen JR, Almeida M, Plotkin LI, Bellido T, Manolagas SC (2003) Kinase-mediated regulation ofcommon transcription factors accounts for the bone-protective effects of sex steroids. J Clin Invest 111:1651-1664

LaMorte A, Kumar N, Bardin CW, Sundaram K (1994) Aromatization of 7 alpha-methyl-19-nortestosterone by human placental microsomes in vitro. J Steroid Biochem Mol Biol 48: 297-304

Langley E, Zhou ZX, Wilson EM (1995) Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J Biol Chem 270:29983-29990

Liu Z, Auboeuf D, Wong J, Chen JD, Tsai SY, Tsai MJ, O'Malley BW (2002) Coactiva-tor/corepressor ratios modulate PR-mediated transcription by the selective receptor modulator RU486. Proc Natl Acad Sci USA 99:7940-7944

Loven MA, Likhite VS, Choi I, Nardulli AM (2001) Estrogen response elements alter coactivator recruitment through allosteric modulation of estrogen receptor beta conformation. J Biol Chem 276:45282-45288 Lutz LB, Jamnongjit M, Yang WH, Jahani D, Gill A, Hammes SR (2003) Selective modulation of genomic and nongenomic androgen responses by androgen receptor ligands. Mol Endocrinol 17:1106-1116

McEwen BS (1980) Binding and metabolism of sex steroids by the hypothalamic-pituitary unit:

physiological implications. Annu Rev Physiol 42:97-110 McKennaNJ, LanzRB, O'Malley BW (1999) Nuclear receptor coregulators: cellular and molecular biology. Endocr Rev 20:321-344 McKenna NJ and O'Malley BW (2000) From ligand to response: generating diversity in nuclear receptor coregulator function. J Steroid Biochem Mol Biol 74:351-356 Migliaccio A, Castoria G, Di Domenico M, de Falco A, Bilancio A, Lombardi M, Barone MV, Ametrano D, Zannini MS, Abbondanza C, Auricchio F (2000) Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation. EMBO J. 19:5406-5417

Miyamoto H, Yeh S, Wilding G, Chang C (1998) Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells. Proc Natl Acad Sci USA 95:7379-7384 Muller JM, Isele U, Metzger E, Rempel A, Moser M, Pscherer A, Breyer T, Holubarsch C, Buettner R, Schule R (2000) FHL2, a novel tissue-specific coactivator of the androgen receptor. EMBO J. 19:359-369

Negro-Vilar A (1999) Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium. J Clin Endocrinol Metab 84:3459-3462 Nimrod A and Ryan KJ (1975) Aromatization of androgens by human abdominal and breast fat tissue. J Clin Endocrinol Metab 40:367-372 Riggs BL, Khosla S, Melton LJ, III (2002) Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 23:279-302 Robyr D, Wolffe AP, Wahli W (2000) Nuclear hormone receptor coregulators in action: diversity for shared tasks. Mol Endocrinol 14:329-347 Roselli CE and Resko JA (2001) Cytochrome P450 aromatase (CYP19) in the non-human primate brain: distribution, regulation, and functional significance. J Steroid Biochem Mol Biol 79: 247-253

Shang Y and Brown M (2002) Molecular determinants for the tissue specificity of SERMs. Science 295:2465-2468

Shull JD, Beams FE, Baldwin TM, Gilchrist CA, Hrbek MJ (1992) The estrogenic and antiestrogenic properties oftamoxifen in GH4C1 pituitary tumor cells are gene specific. Mol Endocrinol, 6:529-535

Simpson ER, Mahendroo MS, Means GD, Kilgore MW, Hinshelwood MM, Graham-Lorence S, Amarneh B, Ito Y, Fisher CR, Michael MD (1994) Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis. Endocr Rev 15:342-355 Sundaram K, Kumar N, Bar din CW (1993) 7alpha-methyl-nortestosterone (MENT): the optimal androgen for male contraception. Ann Med 25:199-205

Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP (1994) Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8:21-30

VerrijdtG, Haelens A, Claessens F (2003) Selective DNA recognition by the androgen receptor as a mechanism for hormone-specific regulation of gene expression. Mol Genet Metab 78:175-185 Yeh S an d Chang C (1996) Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. Proc Natl Acad Sci USA 93:5517-5521 Yeh S, Miyamoto H, Chang C (1997) Hydroxyflutamide may not always be a pure antiandrogen. Lancet 349:852-853

Yeh S, Miyamoto H, Shima H, Chang C (1998) From estrogen to androgen receptor: a new pathway for sex hormones in prostate. Proc Natl Acad Sci USA 95:5527-5532 Yi P, Driscoll MD, Huang J, Bhagat S, Hilf R, Bambara RA, Muyan M (2002) The effects of estrogen-responsive element- and ligand-induced structural changes on the recruitment of cofactors and transcriptional responses by ER alpha and ER beta. Mol Endocrinol 16:674-693 Yin D, Gao W, Kearbey JD, Chung K, He Y, Marhefka CA, Veverka KA, Miller DD, Daltom JT (2003a) Pharmacodynamics of selective androgen receptor modulators. J Pharmacol Exp Ther 304:1334-1340

YinD, XuH, HeY, Kirkovsky LI, Miller DD, Dalton JT (2003b) Pharmacology, pharmacokinetics, and metabolism of acetothiolutamide, a novel nonsteroidal agonist for the androgen receptor. J Pharmacol Exp Ther 304:1323-1333 Zaccheo T, Giudici D, Panzeri A, di Salle E (2000) Combined treatment of Dunning R3327 rat prostatic tumor with the 5alpha-reductase inhibitor PNU 157706 and the antiandrogen bicalutamide. Cancer Chemother Pharmacol 45:31-37 Zhao Q, Chasse SA, Devarakonda S, Sierk ML, Ahvazi B, Rastinejad F (2000) Structural basis of

RXR-DNA interactions. J Mol Biol 296:509-520 Zumpe D, Bonsall RW, Michael RP (1993) Effects ofthe nonsteroidal aromatase inhibitor, fadro-zole, on the sexual behavior of male cynomolgus monkeys (Macaca fascicularis). Horm Behav 27:200-215

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment